tiprankstipranks
Ars Pharmaceuticals, Inc. (SPRY)
NASDAQ:SPRY
US Market
SPRY
ARS Pharmaceuticals
RESEARCH TOOLSreports
Want to see SPRY full AI Analyst Report?

ARS Pharmaceuticals (SPRY) Stock News & Sentiment

567 Followers
Ars Pharmaceuticals Earnings Call Highlights Neffy’s Early Traction
Premium
Company Announcements
Ars Pharmaceuticals Earnings Call Highlights Neffy’s Early Traction
1M ago
SPRY
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
Premium
TipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
2M ago
CTMX
NSRX
ARS Pharmaceuticals Reports 2025 Results and neffy Growth
Premium
Company Announcements
ARS Pharmaceuticals Reports 2025 Results and neffy Growth
2M ago
8K
SPRY
ARS Pharmaceuticals: Buy Rating Reaffirmed on Improved Competitive Outlook After Aquestive’s Anaphylm Setback
Premium
Ratings
ARS Pharmaceuticals: Buy Rating Reaffirmed on Improved Competitive Outlook After Aquestive’s Anaphylm Setback
4M ago
SPRY
Regulatory Setbacks for Anaphylm Enhance ARS Pharmaceuticals’ Competitive Position and Support SPRY Buy Rating
Premium
Ratings
Regulatory Setbacks for Anaphylm Enhance ARS Pharmaceuticals’ Competitive Position and Support SPRY Buy Rating
4M ago
SPRY
ARS Pharmaceuticals: Strategic Positioning and Market Potential for Neffy Justifies Buy Rating
Premium
Ratings
ARS Pharmaceuticals: Strategic Positioning and Market Potential for Neffy Justifies Buy Rating
6M ago
SPRY
ARS Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
ARS Pharmaceuticals Reports Strong Q3 2025 Growth
6M ago
SPRY
More SPRY News >

SPRY News on the Web

Northland Securities Keeps Their Buy Rating on ARS Pharmaceuticals (SPRY)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Stereotaxis (STXS)
TipRanks News
Bullish
ARS Pharmaceuticals announces Health Canada approval of neffy 2 mg
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: ARS Pharmaceuticals (SPRY), Longeveron (LGVN)
TipRanks News
Bullish
ARS Pharmaceuticals initiated with an Outperform at Northland
TipRanks News
Neutral
Northland starts disruptor ARS Pharmaceuticals with an Outperform
TipRanks News
Neutral
Ars Pharmaceuticals Earnings Call Highlights Neffy’s Early Traction
TipRanks News
Neutral
Millennium Management LLC's Strategic Acquisition of ARS Pharmaceuticals Inc Shares
GuruFocus News
Bullish

News Score - Last 7 Days

Very Positive
SPRY
Sector Average
Media Buzz
This Week4 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SPRY’s Media Buzz Sentiment?
4 articles about SPRY were published this week. In an average week, 2 articles are published.
    What is SPRY’s weekly average amount of articles?
    In an average week, 2 articles about SPRY are published.
      What is SPRY’s News Sentiment?
      100% of articles about SPRY were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week